氣動霧化器市場規模、佔有率和成長分析（按適應症、最終用途和地區）- 產業預測 2025-2032

氣動霧化器市場規模預計將在 2023 年達到 8.0405 億美元，從 2024 年的 8.5792 億美元成長到 2032 年的 14.4133 億美元，預測期內（2025-2032 年）的複合年成長率為 6.7%。

氣動霧化器市場是醫療設備產業的關鍵組成部分，專注於滿足患者的呼吸照護需求。這些設備將液體藥物轉化為可供吸入的細霧，增強了對氣喘和慢性阻塞性肺病等呼吸系統疾病的有效治療。由於這些疾病的盛行率不斷上升、人口老化以及人們對呼吸健康管理的認知不斷提高，市場正在穩步成長。此外，技術的進步導致了攜帶式、易於使用的霧化器的出現，進一步刺激了需求。北美和歐洲引領市場，而亞太地區由於空氣污染和醫療保健投資的增加正在迅速擴張。飛利浦偉康和Omron Healthcare等主要企業正在進行創新，以改善患者舒適度和藥物輸送，確保市場持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

氣動霧化器市場規模（依適應症分類）

• 市場概況
• 呼吸激活
• 通風

氣動霧化器市場規模（依最終用途分類）

• 市場概況
• 醫院和診所
• 家庭醫療保健

氣動霧化器市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Philips Healthcare（Netherlands）
• Omron Healthcare, Inc.（Japan）
• PARI GmbH（Germany）
• Drive DeVilbiss Healthcare（USA）
• Medline Industries, Inc.（USA）
• Invacare Corporation（USA）
• GF Health Products, Inc.（USA）
• Briggs Healthcare（USA）
• Allied Healthcare Products, Inc.（USA）
• Aerogen（Ireland）
• Trudell Medical International（Canada）
• Salter Labs（USA）
• Vyaire Medical, Inc.（USA）
• Besco Medical Co., Ltd.（China）
• Rossmax International Ltd.（Taiwan）
• Microlife Corporation（Taiwan）
• Becton, Dickinson and Company（USA）
• Teleflex Incorporated（USA）
• Agilent Technologies, Inc.（USA）
• ResMed Inc.（USA）

結論和建議

Pneumatic Nebulizers Market size was valued at USD 804.05 million in 2023 and is poised to grow from USD 857.92 million in 2024 to USD 1441.33 million by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The pneumatic nebulizers market is a vital component of the medical devices industry, focused on meeting the respiratory care needs of patients. These devices transform liquid medications into a fine mist for inhalation, enhancing the effective delivery of treatments for respiratory conditions like asthma and COPD. The market is experiencing steady growth due to the increasing incidence of such diseases, an aging population, and heightened awareness regarding respiratory health management. Technological advancements have also led to the emergence of portable and user-friendly nebulizers, further driving demand. North America and Europe lead the market, while the Asia-Pacific region is rapidly expanding due to rising air pollution and healthcare investments. Key players, including Philips Respironics and Omron Healthcare, are innovating to improve patient comfort and medication delivery, ensuring the market's continued growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pneumatic Nebulizers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pneumatic Nebulizers Market Segments Analysis

Global Pneumatic Nebulizers Market is segmented by Indication, End Use and region. Based on Indication, the market is segmented into Breath-Actuated and Vented. Based on End Use, the market is segmented into Hospitals & Clinics and Home Healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pneumatic Nebulizers Market

The rising incidence of respiratory ailments such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis significantly propels the growth of the pneumatic nebulizers market. As these conditions demand efficient medication administration directly to the lungs to aid in symptom relief and disease management, there is an escalating need for advanced nebulizer systems. This trend highlights the vital role pneumatic nebulizers play in providing effective therapy for patients suffering from these chronic respiratory illnesses, thereby driving further innovation and investment in this market segment to meet the growing healthcare demands and improve patient outcomes.

Restraints in the Pneumatic Nebulizers Market

The Pneumatic Nebulizers market encounters significant restraints due to the competition posed by alternative respiratory therapies like inhalers and dry powder inhalers. These alternative devices offer convenience, portability, and ease of use, potentially making them more appealing to patients and healthcare providers. As these options continue to gain popularity, they may hinder the growth of the Pneumatic Nebulizers market. Additionally, advancements in inhaler technology and the increasing emphasis on patient-centric treatment approaches can further challenge the market's expansion. Consequently, the presence of these alternative therapies necessitates a strategic response from Pneumatic Nebulizer manufacturers to maintain their market share.

Market Trends of the Pneumatic Nebulizers Market

The pneumatic nebulizers market is experiencing significant growth driven by notable technological advancements that enhance device efficiency and user experience. Innovations such as quieter operation, accelerated drug delivery times, and optimized particle size distribution are becoming increasingly prevalent, facilitating better therapeutic outcomes for respiratory patients. Manufacturers are focusing on user-friendly designs that cater to diverse patient needs, thereby boosting adoption rates among both healthcare professionals and consumers. As awareness of respiratory conditions grows and the demand for effective treatment solutions increases, the pneumatic nebulizers market is positioned for robust expansion, reflecting broader trends towards improved patient-centric healthcare devices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Pneumatic Nebulizers Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Breath-Actuated
• Vented

Global Pneumatic Nebulizers Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Home Healthcare

Global Pneumatic Nebulizers Market Size & CAGR (2025-2032)

• North America (Indication, End Use)
  • US
  • Canada
• Europe (Indication, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Indication, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Indication, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Indication, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PARI GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive DeVilbiss Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GF Health Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Briggs Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allied Healthcare Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerogen (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trudell Medical International (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Salter Labs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Besco Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microlife Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations